PRWeb The Leader Press Release Distribution

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for August 29, 2005 Subscribe to this News Feed    Subscribe to this Podcast Feed
 

Cause of Primary Pulmonary Hypertension (PPH) still unknown but many link it to weight loss drugs

Fen-Phen, Redux, and Pondimin have been off the market for some time but doctors are still diagnosing patients with PPH after taking diet drugs years earlier.

St. Louis, Missouri (PRWEB) August 29, 2005 -- A leading law firm, in association with LawyersandSettlements.com, is keeping the public aware of the prolonged effects of diet drugs and their link to Primary Pulmonary Hypertension (PPH).

According to the American Heart Association, an estimated 500 to 1,000 new cases of PPH are diagnosed in the U.S. each year; most of these cases are women between ages 20 and 40. PPH is a rare and potentially life threatening lung disorder in which the blood pressure in the pulmonary artery of the heart rises far above normal levels for no apparent reason. This serious type of hypertension or high blood pressure is recognized when the average blood pressure is greater than 25 mm Hg at rest.

Physicians began diagnosing patients with PPH in the 1970s and have yet to identify a cause. Experts note that there is typically a delayed diagnosis for up to 10 years and have linked PPH with the use of appetite suppressants and weight loss drugs. Specifically, a study published in the New England Journal of Medicine (1996) found that the use of Fen Phen for three months or longer increased the risk of developing PPH by 23%.

Responding to reports of heart disease linked to Fen-Phen and other weight loss prescription drugs, the FDA recalled the popular diet drugs Redux (dexfenfluramine), Pondimin (fenfluramine) and Fen-Phen (fenfluramine and phentermine) in 1997. Before they were recalled, these appetite suppressants were taken by nearly six to seven million consumers worldwide. Mounting evidence and hundreds of consumer reports links Pondimin and Fen-Phen to Primary Pulmonary Hypertension, heart valve problems, and neurotoxicity of the brain.

The initial symptoms of PPH can include weakness, fatigue, shortness of breath, chest pain, dizzy spells, and fainting. Advanced symptoms of PPH, due to delayed diagnosis, can include bluish lips and skin, ankle and lower leg swelling, increased chest pain, and even death.

A St. Louis-based law firm is investigating whether the use of diet drugs is linked to PPH and is urging patients that have had been diagnosed with PPH to come forward. For more details about this product recall and potential class action lawsuit, visit
https://www.lawyersandsettlements.com/case/pph_class_action

About Online Legal Services Ltd (OLS) and www.lawyersandsettlements.com
OLS is a privately held Internet marketing company that specializes in joint advertising campaigns for lawyers and law firms. Lawyersandsettlements.com offers a comprehensive website with up-to-date information on legal news, class action lawsuits, personal injury cases, settlement details, product recalls, and more. Consumers can complete free case evaluations and subscribe to free newsletters.

Visit us at:
http://www.lawyersandsettlements.com/

Contact us at:
604-608-3435

# # #

OPTIONS
Printer Friendly Version
Email this story to a colleague
CONTACT INFORMATION
Tracy Laxdal
LAWYERSANDSETTLEMENTS.COM
3603034173
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appearshere.